Synthesis and characterization of new platinum(II) complexes with cyclic iminoether-type ligands having the azomethine group out of cycle

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Inorganica Chimica Acta

• Publication date

  2021-10-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.ica.2021.120655
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Metallodrugs are unique: opportunities and challenges of discovery and development

  2020cited by this paper
• Platinum iodido complexes: A comprehensive overview of anticancer activity and mechanisms of action

  2019cited by this paper
• Biological relevance of interaction of platinum drugs with O-donor ligands.

  2019cited by this paper
• Cisplatin: The first metal based anticancer drug.

  2019cited by this paper
• Platinum drugs, copper transporters and copper chelators

  2018cited by this paper
• Platinum coordination compounds with potent anticancer activity

  2017cited by this paper
• A Drug of Such Damned Nature.1 Challenges and Opportunities in Translational Platinum Drug Research.

  2017cited by this paper
• Cytotoxic platinum coordination compounds. DNA binding agents

  2017cited by this paper
• The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.

  2016cited by this paper
• Molecular mechanisms of cisplatin resistance

  2012cited by this paper
• Towards Antitumor Active trans-Platinum Compounds.

  2009cited by this paper
• Molecular mechanisms of resistance and toxicity associated with platinating agents.

  2007cited by this paper
• Trans-platinum complexes in cancer therapy.

  2007cited by this paper
• Synthesis and in vitro antitumor activity of platinum acetonimine complexes.

  2006cited by this paper
• Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches.

  2005cited by this paper
• Synthesis and characterisation of the amidine complexes trans-[PtCl(NH3){HNC(NH2)R}2]Cl (R = Me, Ph, CH2Ph) derived from addition of NH3 to the coordinated nitriles in trans-[PtCl2(NCR)2]

  2005cited by this paper
• Modifications of DNA by platinum complexes. Relation to resistance of tumors to platinum antitumor drugs.

  2005cited by this paper
• Platinum complexes with imino ethers or cyclic ligands mimicking imino ethers: synthesis, in vitro antitumour activity, and DNA interaction properties

  2004cited by this paper
• New metal complexes as potential therapeutics.

  2003cited by this paper
• X-ray structures of the first platinum complexes with Z configuration iminoether ligands: trans-dichlorobis(1-imino-1-methoxy-2,2'-dimethylpropane)platinum(II) and trans-tetrachlorobis(1-imino-1-methoxy-2,2'-dimethylpropane)platinum(IV).

  2002cited by this paper
• Trans-platinum complexes as anticancer drugs: recent developments and future prospects.

  2002cited by this paper
• Structure, Recognition, and Processing of Cisplatin-DNA Adducts.

  1999cited by this paper
• WinGX suite for small-molecule single-crystal crystallography

  1999cited by this paper
• In vitro and in vivo antitumour activity and cellular pharmacological properties of new platinum-iminoether complexes with different configuration at the iminoether ligands.

  1999cited by this paper
• Preparation and characterization of novel trans-[PtCl(2)(amine)(isopropylamine)] compounds: cytotoxic activity and apoptosis induction in ras-transformed cells.

  1999cited by this paper
• DNA adducts of antitumor trans-[PtCl2 (E-imino ether)2].

  1996cited by this paper
• Palladium(II)-Promoted Cyclization Reaction of 4-Hydroxybutyronitrile to 2-Iminotetrahydrofuran. X-ray Structure of cis-[PdCl2{N(H)CCH2CH2CH2O}- (PPh3)]·1/2CH2Cl2

  1996cited by this paper
• Mechanistic and Stereochemical Investigation of Imino Ethers Formed by Alcoholysis of Coordinated Nitriles: X-ray Crystal Structures of cis- and trans-Bis(1-imino-1-methoxyethane)dichloroplatinum(II)

  1995cited by this paper
• Platinum(II) complexes containing iminoethers: a trans platinum antitumour agent.

  1995cited by this paper
• A trans-platinum complex showing higher antitumor activity than the cis congeners.

  1993cited by this paper
• Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action.

  1991cited by this paper
• Parst: A system of fortran routines for calculating molecular structure parameters from results of crystal structure analyses

  1983cited by this paper
• Platinum-195 nuclear magnetic resonance

  1982cited by this paper
• Platinum Compounds: a New Class of Potent Antitumour Agents

  1969cited by this paper
• The inhibition of growth or cell division in Escherichia coli by different ionic species of platinum(IV) complexes.

  1967cited by this paper
• Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode

  1965cited by this paper

• Increase delivery, cytotoxicity, stability and induction of apoptosis in cisplatin by establishing a new complex with methotrexate

  2023cites this paper